134 Views

Avalon Ventures and GSK launch and fund Silarus and Thyritope

Avalon Ventures and GlaxoSmithKline has launched Silarus Therapeutics and Thyritope Biosciences, two San Diego-based early-stage life science firms. Both will receive up to $10 million in Series A funding as well as R & D support from Avalon Ventures and GSK.

Avelas Biosciences Extends Series B Financing to $7.4 Million

Avelas Biosciences, an in vivo cancer diagnostic company for oncologic surgeries, announced that it has closed on the second tranche of its Series B financing bringing the total funds raised in the round to $7.4 million. Participants in the financing included founding investor, Avalon Ventures, as well as existing investors Torrey Pines Investment, WuXi PharmaTech Investments, […]

shutterstock_65181187
383 Views

Neuroscience deals a no-brainer: VCJ

The human brain may be complicated, but more VCs are finding it easy to back drug developers focused on neurological conditions

VC-backed Otonomy files for IPO

Otonomy said Monday that it has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. J.P. Morgan Securities and BofA Merrill Lynch are serving as the lead underwriters. Based in San Diego, Calif., Otonomy is a biopharmaceutical company that develops treatments for ear disorders and diseases. Its backers include Perceptive Advisors, Federated Kaufmann Funds, OrbiMed Advisors, Novo Ventures, TPG Biotech, Avalon Ventures, Domain Associates, RiverVest Venture Partners, Aperture Venture Partners and Osage University Partners.

106 Views

BookBub scores $3.8 mln

BookBub said Thursday that it has closed $3.8 million in Series A financing. The investors included NextView Ventures, Founder Collective, Avalon Ventures and Bloomberg Beta. Headquartered in Cambridge, Mass., BookBub helps readers find ebook deals.

Otonomy scores $49 mln Series D funds

Otonomy said Wednesday that it has closed $49 million in Series D funding. The investors included Perceptive Advisors, Federated Kaufmann Funds, OrbiMed Advisors, Novo Ventures, TPG Biotech, Avalon Ventures, Domain Associates, RiverVest Venture Partners, Aperture Venture Partners and Osage University Partners. Based in San Diego, Calif., Otonomy is a biopharmaceutical company that develops treatments for ear disorders and diseases.

VC-backed Syndax Pharmaceuticals files for IPO

Syndax Pharmaceuticals has filed for an IPO. The number of shares that will be offered as well as the stock’s pricing terms have yet to be set. Deutsche Bank Securities and Jefferies are serving as lead underwriters. Headquartered in Waltham, Mass., Syndax is a Syndax Pharmaceuticals is a developer of epigenetic therapies for treatment-resistant cancers. Its backers include Domain Associates, MPM Capital, Forward Ventures, Pappas Ventures and Avalon Ventures.

Indix Corporation attracts funds led by Avalon and Nexus

Indix Corporation has closed $8.5 million of a $9 million Series A-1 round of financing, co-led by Avalon Ventures and Nexus Venture Partners. Founded in 2010, Indix is a SaaS and big data product intelligence platform based in Seattle with a product development and engineering team in Chennai, India.

Ad Tech Startup Nanigans Raises $5.8 Million Led by Avalon Ventures

Nanigans, a Boston-based startup that makes advertising technology software to help advertisers maximize their social and mobile advertising, has raised $5.8 million led by Avalon Ventures. The company is describing the round as “Series A.1 funding,” having raised $3.1 million in 2011, including from Avalon.

Simulmedia Raises $5 Million from Union Square Ventures and Others

The New York-based media marketing firm Simulmedia has raised another $5 million in funding from Time Warner Investments, Avalon Ventures, and Union Square Ventures, according to an SEC Filing. The investors have collectively invested roughly $32 million in Simulmedia since its 2009 founding.

Kaltura Secures $25m New Funding

Kaltura, an open source video platform, has secured $25 million of funding from new investors Mitsui & Co. Global Investment, Inc. and ORIX Ventures. Existing investors Nexus Venture Partners, Intel Capital, .406 Ventures and Avalon Ventures also participated.

peHUB First Read

Click on this morning’s First Read to find out about Avalon Ventures’ tenth fund, Mango Health’s stellar fundraising and why venture capital is most definitely not broken.

PEHUB Community

Join the 12504 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget